Dr. Duk-Woo Park and Dr. C. Michael Gibson Discuss: A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement
Loading…
Disclosures: TBA